Acorda Therapeutics reported $184.98M in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Amgen AMGN:US USD 37.16B 1.46B
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 609.73M 411.31M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Mannkind MNKD:US USD 367.5M 509K
Merck MRK:GR EUR 9.27B 119M
Moderna Inc MRNA:US USD 922M 281M
Novartis NOVN:VX USD 21.24B 2.55B
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M